Cytek Biosciences, Inc. · NASDAQ:CTKB
Yan Ming exercised options for 22,179 Cytek Biosciences, Inc. shares (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Yan Ming (Director, CHIEF TECHNOLOGY OFFICER) exercised options for 22,179 Cytek Biosciences, Inc. shares, leaving 4,932,580 shares. Filed May 20, 2026 (Form 4).
- Options exercised
- 22,179 shares
- Holding after
- 4,932,580 shares
- Trading plan
- No
- Role
- Director, CHIEF TECHNOLOGY OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Option exercise | 4,908 | 4,920,841 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 1,224 | US$3.55 | 4,919,617 | Direct |
| May 18, 2026 | Common Stock | Option exercise | 3,683 | 4,923,300 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 919 | US$3.55 | 4,922,381 | Direct |
| May 18, 2026 | Common Stock | Option exercise | 4,108 | 4,926,489 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 1,025 | US$3.55 | 4,925,464 | Direct |
| May 18, 2026 | Common Stock | Option exercise | 9,480 | 4,934,944 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 2,364 | US$3.55 | 4,932,580 | Direct |
Source
Related
- Cytek Biosciences, Inc.
- Yan Ming
- Cytek Biosciences, Inc. shareholders
- Form 4 · Yan Ming · Aug 20, 2026
- Form 4 · Yan Ming · Jun 16, 2026
- Form 4 · Jiang Wenbin · Aug 20, 2026
- Form 4 · McCombe William D. · Aug 20, 2026
- Form 4 · Muir Glenn P · Aug 20, 2026
- Form 4 · Holder Michael · Aug 20, 2026
- Form 4 · Chin Richard · Aug 20, 2026